Nov 09, 2020
1:4
For every 4 shares held, investors received 1.
The split itself did not change the total investment value.
Opus Genetics, Inc. (GETTEX:R3X1) operates in the Pharmaceuticals: major industry.
Opus Genetics, Inc. company overviewOpus Genetics, Inc.'s most recent stock split was on November 9, 2020. It was a 1-for-4 reverse split, so shareholders received 1 share for every 4 they held.
Opus Genetics, Inc. (GETTEX:R3X1) has split its stock 4 times: a 1-for-100 reverse split on May 16, 2005, a 1-for-10 reverse split on May 5, 2017, a 1-for-12 reverse split on April 12, 2019, and a 1-for-4 reverse split on November 9, 2020.
Opus Genetics, Inc. has split its stock 4 times. This history records 4 reverse splits between May 16, 2005 and November 9, 2020.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Opus Genetics, Inc.'s 1-for-4 reverse split on November 9, 2020, every 4 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Opus Genetics, Inc. has not announced a new split in our records. Its most recent split was on November 9, 2020, 5 years ago. Companies announce splits in advance, and any new GETTEX:R3X1 split will appear on this page.